A new study suggests the hormone progestin, when taken as part of component of hormone replacement therapy following menopause, contributes to problems with hearing and speech processing in older women, suggesting drugmakers should conduct better sensory testing during drug development. Researchers said such advice may be particularly useful in developing drugs for older individuals.

Full Story:

Related Summaries